Pallas Health vs Oak Longevity: price, meds, and care compared
Quick verdict: For patients choosing between Pallas Health vs Oak Longevity, Pallas centers clinician choice between brand-name pens and compounded options with provider care included, while Oak emphasizes the lowest flat prices and no subscription. Choose based on whether clinician-picked brand access and included provider care matter more than the lowest monthly compound price.
See Pallas Health plans and pricing
How Pallas Health vs Oak Longevity differ at a glance
Both sell clinician-reviewed GLP-1 plans online and may offer compounded semaglutide and tirzepatide. The most distinctive differences supported by the source are: pricing structure and intro pricing, access to FDA-approved brand-name medications, whether provider care is bundled, and subscription versus non-subscription billing.
Direct comparison table
| Criteria | Pallas Health | Oak Longevity |
|---|---|---|
| Starting price | $139 first month for compounded semaglutide | $133/month for semaglutide |
| Ongoing price model | Compounded semaglutide $597 every 12 weeks (about $199/mo avg); compounded tirzepatide $897 every 12 weeks ($299/mo avg); brand-name cash-pay monthly | Flat monthly price for all dosages: semaglutide $133/mo; tirzepatide $199/mo; billed monthly non-recurring |
| Brand-name medications | Offers FDA-approved Wegovy, Ozempic, Zepbound, Mounjaro when appropriate | Offers compounded semaglutide and tirzepatide; no brand-name pens noted |
| Provider care and communications | Provider care, check-ins and messaging included in plan price, no membership fee | Free health coaching included; board-certified physicians review cases |
| Subscription model | No membership fees; plans renew every 12 weeks for compounded plans | No subscriptions or membership fees; billed monthly on a non-recurring basis |
| Shipping and fulfillment | Free expedited discreet shipping; compounded in the USA | Free shipping with tracking; same-day approval available for qualifying patients |
| Regulatory note | Compounded medications are not FDA-approved | Compounded medications are not FDA-approved |
Pricing and billing: which is cheaper for ongoing use
Pallas advertises a lower intro month for compounded semaglutide at $139 first month, with renewal priced as $597 every 12 weeks, a $199/month average, and compounded tirzepatide starting $179 first month then $897 every 12 weeks ($299/mo avg). Oak lists semaglutide from $133/month and tirzepatide from $199/month as a flat price for all dosages. Oak bills monthly on a non-recurring basis and states no subscription is required, while Pallas compounds renew every 12 weeks for its compounded plans. The article preserves that both providers use compounded products when applicable and that compounded medications are not FDA-approved.
Check Oak Longevity current pricing
Access to brand-name GLP-1s and clinician choice
Pallas explicitly offers clinician-selected options including FDA-approved Wegovy, Ozempic, Zepbound and Mounjaro or clinician-personalized compounded semaglutide or tirzepatide prepared in the USA when a brand medication is not the right fit. Oak emphasizes compounded semaglutide and tirzepatide prepared by licensed compounding pharmacies and does not list brand-name pens. If access to a clinician decision that may prescribe FDA-approved brand medications matters, the source supports that Pallas offers that route.
Explore Pallas Health medication options
Care model, approvals and logistics
Pallas includes provider care, ongoing check-ins and care-team messaging inside plan prices and operates 100% online with asynchronous intake in most states; a video visit is required in seven states plus Washington, D.C. Oak describes asynchronous review by a licensed physician, board-certified physicians in your state, free health coaching, and same-day approval for qualifying patients. Both note that eligibility is determined by a US-licensed clinician and that compounded products are not FDA-reviewed finished products.
When shipping, refunds, and cancellations differ
Pallas offers free expedited and discreet shipping and notes compounded plans renew every 12 weeks, so cancellation timing matters. Oak offers free shipping with tracking, states three-month prescriptions are billed upfront in some cases, and says no refunds are available after physician approval and once medication has shipped. Both sources caution that compounded medications are not FDA-approved.
Final thoughts on Pallas Health vs Oak Longevity
Pallas Health centers clinician choice between brand-name pens and compounded preparations and bundles provider care and messaging in plan prices, with compounded semaglutide $139 first month then $597 every 12 weeks. Oak Longevity focuses on lower flat monthly compound pricing, semaglutide from $133/month and tirzepatide from $199/month, no subscriptions, and free health coaching.
Visit Oak Longevity to start the intake
Choose Pallas Health if you want a clinician to decide between brand-name GLP-1 pens and a compounded option, and if you prefer provider care, check-ins and messaging included in your plan price. Choose Oak Longevity if your priority is the lowest flat compounded price per month for semaglutide or tirzepatide and a non-subscription, billed-monthly model.